0 Σχόλια
0 Μοιράστηκε
167 Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Global Circular RNA Therapeutics Market Size, Share, and Trends Analysis Report – Industry Overview and Forecast to 2033" According to the latest report published by Data Bridge Market Research, the Circular RNA Therapeutics Market The global Circular RNA Therapeutics market size was valued at USD 784 Million in 2025and is expected to reach USD 4188.13 Million by 2033, at a CAGR of 23.30% during the forecast period The market growth is largely fueled by the growing adoption and...0 Σχόλια 0 Μοιράστηκε 4 Views 0 Προεπισκόπηση
-
Rna Therapeutics Market Comprehensive Statistics, Growth Rate, and Future Trends 2035This report presents a detailed, data-driven analysis of the global RNA Therapeutics Market size, offering insights into historical performance, current dynamics, and projections from 2025 to 2035. With a strong emphasis on factual assessment, the report refrains from speculative assumptions and aims to support business decisions through accurate forecasting and strategic...0 Σχόλια 0 Μοιράστηκε 111 Views 0 Προεπισκόπηση
-
Small Interfering RNA Market: How Is RNAi Therapeutics Transforming Gene Silencing Medicine?Small interfering RNA therapeutics — the double-stranded RNA molecules of approximately twenty-one to twenty-three nucleotides that trigger RNA interference silencing specific disease-causing genes through the RISC (RNA-induced silencing complex) pathway — represent one of the most transformative pharmaceutical modalities in modern medicine, with the Small Interfering RNA Market...0 Σχόλια 0 Μοιράστηκε 243 Views 0 Προεπισκόπηση
-
Nucleic Acid Therapeutics CDMO Market to Reach $4.9B by 2031: Inside the 11.09% CAGR SurgeMarket Overview The global nucleic acid therapeutics CDMO market size was valued at USD 1,908.41 million in 2022. It is estimated to reach USD 4,917.52 million by 2031, growing at a CAGR of 11.09% during the forecast period (2023–2031). The global Nucleic Acid Therapeutics CDMO market continues to evolve rapidly, driven by shifting consumer trends, rising...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση